Introduction
Obesity and overweight, caused by multifacetedp hysicala nd environmental factors, have become global issues because of their association with ah igh risk of cardiovascular diseases, [1] diabetes, [2] musculoskeletal disorders, [3] hypertension, [4] and severalt ypes of cancers. [5] According to thef act sheetso ft he World Health Organization, nearly 13 %o ft he world's adult population were obese and 39 %w ere overweight in 2014. [6] Fighting obesityi so ne of the top priorities of health departments.A lthough pharmacotherapyi ss ubordinate to individual lifestylea djustments, it is an indispensable treatment in combating obesity.M any therapeutica gentsu sed to treat obesity have been found to be associated with seriousa dverse reactions. [7] Fenfluramine, an antiobesity medicine once approved by the US FDA in 1973, was withdrawn in 1997 due to the risk of valvular heart disease. [8] Although orlistat is now available, it is currently involved in ad ebate regarding the likelihood of causingl iver damage. [9] Therefore, searching for new cost-effectivea ntiobesity medicines with fewer side effects has been one of the hot research topics over the past decades. [10] Higher fungi belonging to the genus Stereum produce diverse bioactive secondary metabolites.S everals esquiterpenoid skeletons were first isolated from this genus, including hirsutane-type, [11] sterpurane-type, [12] and stereumane-type [13] sesquiterpenes.M oreover,s ome homo-a nd heterodimeric sesquiterpenes with variousb iological activities were recently obtained from this genus. [14] We have investigated the basidiomycete Boreostereumv ibrans (synonym Stereum vibrans), which is knownt op roduce as ignificant pancreatic lipase inhibitor with an unusualf used b-lactone,n amedv ibralactone (IC 50 of 0.4 mgmL À1 ). [15] Some important progress has been made in both elucidating the biosynthetic pathway and modifying the structure of this molecule. [16] To explore more interesting compounds from this productive strain, as cale-upf ermentation (1200 L) wasc onducted, which resulted in the isolation of sixteen oxime and oxime esters with av ibralactone backbone. Natural products possessing an oxime group are rare, andt hey have been found to originate from sponges, bacteria, fungi, and plants. [17] These types of compounds exhibit various activities, including strong antibiotic activity, [16a, 17j-l] cytotoxicity, [ 17 g] inhibition of insect juvenile hormonep roduction, [17d] dexamethasone glucocorticoid receptor binding, [17 f] and phosphorylated cholinesterase regeneration.
[17d]
Interestingly,t he monomers vibralactoxime A(1)a nd vibralactoxime B(2)c an play the role of building blocks to form polymers via the formation of an ester bond between the carbonyl and oxime hydroxy groups. All of the polymers can be divided into four categories depending on the starting and terminatings caffolds:a )starting with 1 and ending with the 2,3-Avariety of novel natural products with significant bioactivities are produced by the basidiomycete Boreostereumv ibrans.I n the present study,w ed escribe 16 novel natural oximes and oxime esters with av ibralactone backbone,v ibralactoximes, which were isolated from the scale-up fermentation broth of B. vibrans.T heir structures were determined through extensive spectroscopic analyses. These compounds represent the first oxime esters from nature.T he hypothetical biosynthetic pathway of these compounds was also proposed. Seven compounds exhibited significant pancreatic lipase inhibitory activity,w hile ten compounds exhibited cytotoxicities against five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW480), with IC 50 values comparable with those of cisplatin. epoxy vibralactone derivative(3), b) startingw ith 1 and ending with the cyano group-containing derivative of 1 (4, 5); c) starting with 1 and endingw ith vibralactone (6, 7), and d) starting with 1 or 2 and endingw ith 1 (8-16). Polyoxime ester bonds were found for the first time in natural products.
Herein, we describe the isolation,s tructural elucidation,b iosynthetic supposition, cytotoxicity,a nd pancreatic lipase inhibitory activity of vibralactoximes 1-16 (Figure 1 ).
Results and Discussion
The filtrate of as cale-upf ermentation broth of B. vibrans (1200 L) was concentrated under reduced pressure and then partitioned between ethyl acetate and water four times to afford an ethyl acetate layer (856 g). Subsequently,t he mycelia were soaked in choroform/methanol (1:1), and the extract was evaporated and then dissolved in water,w hich was extracted with ethyl acetate three times to afford an ethyl acetate layer (362 g). The total organic extract (1218 g) was purified using repeated silica gel, SephadexL H-20, medium-pressure liquid chromatographic approaches and preparative highperformance liquid chrimatography (HPLC)t oa fford sixteen oximes and oxime esters (Figure 1 Table 1 ). All of these data, as well as the partial heteronuclear multiple bond correlations( HMBCs), were highly similart ot hose of vibralactone,e xcept that the hydroxymethyl at d C = 61.3 ppm of vibralactone was changed to an sp 2 -hybridized methane at d C = 146.5 ppm (C-13), which was supported by the HMBC correlations from d H = 7.99 ppm (1 H, s, H-13) to d C = 131.3 (d, C-2), 141.1 (s, C-3), and 36.7 ppm (t, C-4).The above resultsi ndicated that the main differenceb etween them was the substituent at C-3. According to the molecular formula, the group substituted at C-3 in 1 must have the composition CH 2 NO. In addition, the unique 3 J HMBC correlation from the hydroxyl proton at d H = 10.53 ppm (1 H, s) to C-13 indicated that the carbona tom and hydroxyl group were separated by an itrogen atom (Supporting Information, Figure5S). Therefore, considering aforementioned evidences and the chemical shift feature of C-13 (d C = 146.5 ppm), the remaining unassigned atoms of an itrogen, an oxygen, and two protons were determined to be an unusual In order to determine the absolute configurations of 1, as emisynthesis of this molecule was achieved from vibralactone by two steps (Scheme 1). The semisynthesis of 1 commencedw ith vibralactone, am ajor compound in this crude extract, which was oxidized with pyridinium chlorochromate (PCC) to give 17 as ac olorless oil in 78 %y ield.
[15b, 16a] Aldehyde 17 was subjected to react with hydroxylamine hydrochloride to afford 1a as ap ale yellow oil in high yield (90 %). [18] The 1 HNMR data of 1a,a sw ell as circulard ichroism (CD) and UV/ Vis spectra matched those of the natural isolate 1 fabulously ( Figure 2 ; Figures A, D, and Ei nt he Supporting Information). Moreover,t he presence of oxime group in the conjugated diene in 1 led to the red shift of its CD spectrum compared with that of vibralactone, as shown in Figure 2 . All pieceso f evidences above indicated that the absolute configurations of 1 were 1 R,5S,which were the same as vibralactone. Vibralactoxime B(2)w as obtained as al ight yellow oil and determined to have am olecular formula of C 13 H 19 NO 4 based on the ion peak of HR-EI-MSa tm/z 253.1314 (calcd 253.1312). Many of the structuralc haracteristics of 2,i ncluding the oxime group andi sopentenyl moiety,w ere found to be the same as those of vibralactoximeA(1)b ased on preliminarya nalyses of the 1D and2DN MR spectra (Table 1) . However,t he protons at d H = 3.63 ppm (3 H, s) were correlated to the carbonyla td C = 173.5 ppm (s, C-7) in the HMBC spectrum,w hereas the cross peak between the hydroxyl proton at d H = 4.18 ppm (1 H, d, J = 5.9 Hz) and proton at d H = 4.27 ppm (1 H, ddd, J = 6.0, 5.9, 1.8 Hz, H-5) in the 1 H-1 HC OSY spectrum was also observed ( Figure 12 Si nt he Supporting Information). All of the aforementioned spectrald ata suggested that 2 was ad erivative of 1,i nw hich the b-lactoneg roup was opened and the carboxyl was methyl esterified. The key ROESY correlation between H-5 and H-8 (2.62, dd, J = 13.9, 7.6Hz; 2.20, dd, J = 13.9, 7.6 Hz) demonstrated the same configurations between 1 and 2.
The molecular formula of vibralactoximeC ( 3) CNMR spectroscopic data revealed the presence of 26 carbon signals, whichw ere classified by distortionless enhancement by polarization transfer (DEPT) and HSQC spectra into the categories of five methyls, five methylenes (with one oxygenated), seven methines (with three oxygenated), and nine nonprotonedc arbons (three carbonyls, three olefinic carbons, and one oxygen bearing carbon)( Ta ble 2). Detailed analyses of the 1D and 2D NMR spectra indicated the existence of two isolated vibralactone skeletons. One of the moieties (fragment A, Figure 3 HC OSY correlations were completely consistent with the assignments. VibralactoximeD(4)was obtained as ayellow oil with the elemental composition C 24 H 28 N 2 O 5 (twelve degrees of unsaturation), which was determined by HR EI-MS (ion peak at m/z: 424.1998, calcd 424.1987). In the 13 CNMR and DEPT spectra, the signals were present in pairs, implying that 4 might be adimer.Detailed analyses of the1Dand 2D NMR spectroscopic data showed that am oiety of 4 was the same as fragment A of 3,w hile the other partp ossessed similars ignal characteristics to the b-lactone-opened vibralactone, except for the substituenta tC -3' (Table 2) . In this moiety,k ey HMBC correlations from the protona td H = 6.82 ppm (s, H-2')t ot wo quaternary carbonsa td C = 115.0 (s, C-3')a nd 116.8 ppm (s, C-13') ( Figure 32 Si nt he Supporting Information) suggested that the substituent at C-3' was ac yano group (Figure 3) , which was biologically produced through the elimination of awater molecule of an oxime group.T he infrared (IR) absorption bands at 2225 cm À1 confirmed the presence of the cyano group (Figure 35 Si nt he Supporting Information). [19] Considering the overall formula of 4,a ne ster bond was determinedt ob eb etween the oxime hydroxyl and C-7',asd escribed in 3. (Figure 44 Si nt he Supporting Information), which revealed that two moieties of this trimer were the same as those of 4.A nother moiety that was characterized by an opened b-lactone group and invisible oxime hydroxyl signal was constructed from the remaining signals. These data led to the connectivity of the aforementioned three moieties of 5,a ss hown in Figure 1 , for which we proposed the name vibralactoxime E.
Vibralactoxime F(6)p resented ap seudomolecular ion peak at m/z 452.2046 [M + Na] + in the HR ESI-MS spectrum,i ndicating am olecular formula of C 24 + , which was 221 mass units greater than that of vibralactoxime F(6), indicating that 7 was at rimer.T his assumption was confirmed by 1D and 2D NMR spectrala nalyses. The 1 HÀ 1 HC OSY and HMBC spectra displayedt hree isolated moieties, which belonged to two vibralactoxime A(1)s caffolds and av ibralactone scaffold.T he upfield shift of two carbonyls (d C = 170.6 and 169.1 ppm) and the disappearance of two oxime hydroxyls, as well as the active hydrogen at d H = 3.91 ppm (t, J = 5.5Hz), which correlated to am ethylene at d H = 4.12 (dd, J = 14.0, 5.5, H-13''a) and 4.13 ppm (dd, J = 14.0, 5.5, H-13''b) in 1 HÀ 1 HC OSY spectrum, suggested that the b-lactone groups of two units were opened andh ad been esterified, and that the vibralactone component is the tail unit. Therefore, the sequence of the aforementioned three moieties and the connected positions of 7 are described in Figure1.
VibralactoximesH-L (8-12)w ere isolated as yellow gums and identified as ag roup of polyether derivatives ranging from dimer to hexamer.T he molecular formulas of compounds 8 to 12 were assigneda sC 24 HNMR spectra of these compounds could be classified into three characteristics ignal areas:a )peaks at approximately 10.2 ppm, the oxime hydroxyl signal was roughly displayed as as inglet in this area;b )peaks distributed in 7.9-8.5 ppm, the methines of the oxime double bond (H-13) exhibited in this area. The rules for this area were that H-13 of the first part of these polymers was mainly present as singlets at d H = 8.42 ppm, while H-13 of the last part was presented as singletsa td H = 7.95 ppm, and the others appeared as overlapped signals at approximately d H = 8.36 ppm; c) the singlets that appeared at 6.10-6.60ppm were associated with H-2. In vibralactoxime A(1), H-2 was as inglet at d H = 6.04 ppm. When it polymerized, the H-2 of the first moiety shifted downfield to 6.46 ppm, the last moiety shifted downfield to 6.11-6.13 ppm, andt he other moieties shiftedd ownfield to 6.54 ppm as ac luster of signals (Figure 4) . The number of polymer units could be easily deduced from the number of the integration of hydrogen atoms in the (b) and (c) areas, as well as the mass spectra. Although there is al ack of 13 CNMR spectra due to the scarcityo fc ompounds 11 and 12,a ll these data could enable completion of the structures of 8 to 12,f or which we proposed the name vibralactoximes H-L ( 13 CNMR experiments. The differences betweent hese polymers and vibralactoximes H-L (8-12)w ere that the b-lactoneg roup of the first scaffold was opened, and the carboxyl had been methyl esterified. The otherp arts of these polymers were the same as their counterparts, in whicht he b-lactone group remained unopened.
The biogenetic pathway of vibralactoneh as previously been illustrated.
[16b] Here, we presentaproposed biogenetic pathway of all the compounds by referring to the biosynthetic pathway of vibralactone( Scheme 2). It is hypothesized that phydroxybenzoyl methylaminew as prenylated and oxidized by as eries of oxidation reactions to produce vibralactamine (an assumed intermediate). [20] According to the literature, the oxime group is oxidized from an amino group, which was catalyzed by an open reading frame,N coL.
[21] Therefore, the amino group of vibralactamine was oxygenated followed by ad ehydration process to produce vibralactoxime A(1). Vibralactoxime Ac ould serve as ap recursort op roduce the other compounds. Because we have not yet isolated any C-13 cyano vibralactone monomers, it was hypothesized that the dehydration procedure from oxime to cyano group was performed after the polymerization.
Because natural products containing an oxime group are rarely encountered, their bioactivitiesg reatlya roused our curiosity.V ibralactonee xerted pancreatic lipase inhibitory activity through nucleophilic attack on its b-lactone group by the serine residue of pancreatic lipase to form as toichiometric acyl-enzymec omplex. [22] Some of the vibralactoximes still pos-
www.chemistryopen.org sessed the b-lactone function, whichi st he reason why we tested their pancreatic lipase inhibitory activities. Interestingly, compounds 1, 4, 5, 7, 9, 10,a nd 11 exhibited strongerp ancreatic lipase inhibitory activities than vibralactone, which was used as one of the positive controls( the other positive control was orlistat);c ompounds 6 and 12 exhibited low activities, and the other opened b-lactone group compounds were inactives (Table 3a nd Page 7i nt he Supporting Information). From the resultswecould postulate that a) the cleavage of the b-lactone function led to inactivity on pancreatic lipase,b )the existence of the oxime group could enhancet he pancreatic lipase inhibitory activities, and c) it was more likely that the molecular lengths were related to the activities to al arge extent because the pentamer vibralactoxime K(11)r anked first in terms of pancreatic inhibitory activity. Moreover, all these compounds were evaluated for their cytotoxicities against five humanc ancerc ell lines (promyelocytic leukemia HL-60, hepatoma SMMC-7721, lung adenocarcinoma A-549, breast adenocarcinomaM CF-7, and colon adenocarcinoma SW480 cells) using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell proliferation assay,a s previously reported.
[23] Notably,c ompounds 7, 9,a nd 10 exhibited significant cytotoxicities against HL-60, MCF-7, and SW480 with IC 50 values comparable with those of cisplatin. Compounds 4-6, 8, 11, 12, 14,a nd 15 exhibited moderate cytotoxic activities (Table 4) .
Conclusion
Af urtherc hemical investigation of the culture broth of B. vibrans led to the discovery of sixteen structurally and biogenetically novel oxime-group-containing vibralactone derivatives. Notably,t his work exemplified oxime-group-bearing natural products discovered fromh igherf ungi fort he first time. Vibralactoxime A(1)w as ab uilding block assembling various polymers with diverse activities, including pancreatic lipase inhibitory activity and cytotoxicity.Apostulated biosynthetic pathway for these compounds was provided in Scheme 1. Their diverse bioactivities have broadened our horizons in structural modifications of vibralactone for developing stronger bioactive molecules. Moreover,f urtherb iosynthetic effort should shed light on the proposed biosynthetic pathway for these compounds. 
Experimental Section General
Optical rotations (OR) were recorded on aJASCO P-1020 digital polarimeter (Horiba, Kyoto, Japan). UV/Vis spectra were obtained using aS himadzu UV2401PC spectrometer (Shimadzu, Kyoto, Japan). CD spectra were tested on an Applied Photophysics Chirascan Circular Dichroism Spectrometer (Applied Photophysics Limited, Leatherhead, Surrey,U K). IR spectra were obtained using aB ruker Te nsor 27 FT-IR spectrometer (Bruker Optics, Inc.,B illerica, MA) with KBr pellets. HR EI-MS were recorded on aW aters AutoSpec Premier P776 instrument (Waters, Milford, MA, USA). HR ESI-MS were recorded on an Agilent 6200 Q-TOF MS system (Agilent Te chnologies, Santa Clara, CA, USA). NMR spectra were measured on aB ruker AvanceIII 600 MHz spectrometer (Bruker Biospin GmbH, Karlsruhe, Germany). Silica gel (200-300 mesh, Qingdao Haiyang Chemical Co.,L td, P. R. China) and Sephadex LH-20 (Amersham Biosciences, Sweden) were used for column chromatography (CC). Medium-pressure liquid chromatography (MPLC) was performed on aB üchi Sepacore System equipped with pump manager C-615, pump modules C-605 and fraction collector C-660 (Büchi Labortechnik AG, Switzerland), and columns packed with Chromatorex C-18 (40-75 mm, Fuji Silysia Chemical Ltd.,J apan). Preparative HPLC was performed on an Agilent 1260 liquid chromatography system equipped with two type of Zorbax SB-C18 columns (9.4 mm 150 mm and 21.2 mm 150 mm, particle size 5 mm).
Five human cancer cell lines were used to evaluate the cytotoxicities of these isolated compounds:t he HL-60 (ATCC CCL-240) human myeloid leukemia cell line, the SMMC-7721 human hepato- The pH was adjusted to 6.0-6.5 before autoclaving 3400 bottles of 500 mL Erlenmeyer flasks, each containing 350 mL of above-mentioned culture medium, which were then inoculated with B. vibrans strains. Fermentation was carried out on as haker at 150 rpm for 25 di ndarkness seven times.
Extraction and isolation
The culture broth of B. vibrans (1200 L) was filtered to separate the culture fluid and mycelia. The filtrate was concentrated in vacuo then extracted with EtOAc four times (total 200 L). Meanwhile, the mycelia were soaked with CHCl 3 /MeOH (1:1) (total 90 L, 330 L, 3d), and the extraction was evaporated under reduced pressure then partitioned between EtOAc and water to give an EtOAc layer À6 % w/w), 13 (11mg, 9.03 10 À6 % w/w).
